AA Shamshirsaz, MR Bekheirnia, M Kamgar, N … - BMC Endocrine Disorders, 2003 - biomedcentral.com Two hundred twenty patients entered the study. Physicians collected demographic
and anthropometric data and the history of therapies as well as menstrual
histories. Patients have been examined to determine their pubertal status. ... Cited by 35 - Related articles - Cached - All 8 versions
- Free from Publisher S Swaminathan, VA Fonseca, MG Alam, SV … - Diabetes Care, 2007 - Am Diabetes Assoc The central importance of iron in the pathophysiology of disease is derived from
the ease with which iron is reversibly oxidized and reduced. This property,
while essential for its metabolic functions, makes iron potentially ... Cited by 32 - Related articles - BL Direct - All 6 versions
… N Angelopoulos, G Anagnostopoulos, E Gotsis … - Br J Haematol, 2006 - pt.wkhealth.com Recently introduced chelation regimens that combine deferoxamine (DFO) and
deferiprone have been shown to have greater efficacy in promoting iron excretion
than either chelator alone and have been associated with rapid reduction of ... Cited by 29 - Related articles - BL Direct - All 5 versions
SC Wang, KH Lin, JPS Chern, MY Lu, ST Jou, … - Clinical Infectious Diseases, 2003 - UChicago Press Featured in New York Times "Searching the Web for Flu Outbreaks" November 28,
2008 Using Internet Searches for Influenza Surveillance Philip M. Polgreen,
Yiling Chen, David M. Pennock, and Forrest D. Nelson One study, published ... Cited by 20 - Related articles - BL Direct - All 6 versions
NG Angelopoulos, A Goula, G Rombopoulos, V … - Journal of Bone and Mineral Metabolism, 2006 - Springer Treatment with transfusion programs and chelating therapy has considerably
prolonged survival in thalassemic patients [1]. However, as a result of
hypertransfusion therapy and increased longevity, iron tissue toxicity has ... Cited by 13 - Related articles - BL Direct - All 4 versions
JCN Chan, V Malik, W Jia, T Kadowaki, CS … - Jama, 2009 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 12 - Related articles - All 4 versions
JPS Chern, KH Lin - Journal of Pediatric Hematology/Oncology, 2002 - journals.lww.com From the Department of Family Medicine, Tao-Yuan Hospital, Department of Health,
Tao-Yuan (JPSC) and the Department of Pediatrics, National Taiwan University
Hospital, College of Medicine, National Taiwan University (K.-HL), Taiwan, ... Cited by 11 - Related articles - BL Direct - All 3 versions
A Christoforidis, V Perifanis, I Tsatra, E … - Diabetes research and clinical practice, 2007 - Elsevier Glucose metabolism disturbances are frequently reported among patients with
β-thalassaemia major on conventional treatment consisted of regular blood
transfusions and adequate chelation treatment. Aim of this study was to ... Cited by 6 - Related articles - All 10 versions
J Suvarna, H Ingle, CT Deshmukh - Indian Pediatrics, 2006 - indianpediatrics.net From the Department of Pediatrics, Seth GS Medical College and KEM Hospital,
Parel, Mumbai 400 012, India. ... Manuscript received: February 18, 2005,
Initial review completed: April 25, 2005, Revision accepted: November 24, 2005. Cited by 6 - Related articles - Cached - BL Direct - All 8 versions
CH Wang, KH Wu, FJ Tsai, CT Peng, CH Tsai - Hemoglobin, 2006 - informahealthcare.com While hypertransfusion and subcutaneous iron chelation therapy have increased
longevity of patients with β-thalassemia (thal) major, endocrinopathies have
become more common and impair the quality of their lives. Additionally, ... Cited by 4 - Related articles - BL Direct - All 4 versions
